4.6 Article

Design and characterization of a time-domain optical tomography platform for mesoscopic lifetime imaging

Journal

BIOMEDICAL OPTICS EXPRESS
Volume 13, Issue 9, Pages 4637-4651

Publisher

Optica Publishing Group
DOI: 10.1364/BOE.460216

Keywords

-

Funding

  1. National Institutes of Health [R01CA207725, R01CA237267, R01CA250636]

Ask authors/readers for more resources

We report on a novel time-domain mesoscopic fluorescence molecular tomography (TD-MFMT) system designed for multiplexed molecular imaging in turbid media, demonstrating high sensitivity and specificity. Phantom studies and ex vivo tumor imaging validate the system's potential for imaging deep targets and resolving intra-tumoral heterogeneity.
We report on the system design and instrumental characteristics of a novel time-domain mesoscopic fluorescence molecular tomography (TD-MFMT) system for multiplexed molecular imaging in turbid media. The system is equipped with a supercontinuum pulsed laser for broad spectral excitation, based on a high-density descanned raster scanning intensity-based acquisition for 2D and 3D imaging and augmented with a high-dynamical range linear time-resolved single-photon avalanche diode (SPAD) array for lifetime quantification. We report on the system's spatio-temporal and spectral characteristics and its sensitivity and specificity in controlled experimental settings. Also, a phantom study is undertaken to test the performance of the system to image deeply-seated fluorescence inclusions in tissue-like media. In addition, ex vivo tumor xenograft imaging is performed to validate the system's applicability to the biological sample. The characterization results manifest the capability to sense small fluorescence concentrations (on the order of nanomolar) while quantifying fluorescence lifetimes and lifetime-based parameters at high resolution. The phantom results demonstrate the system's potential to perform 3D multiplexed imaging thanks to spectral and lifetime contrast in the mesoscopic range (at millimeters depth). The ex vivo imaging exhibits the prospect of TD-MFMT to resolve intra-tumoral heterogeneity in a depth-dependent manner.(c) 2022 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available